Eli Lilly and Co. said it discontinued a last-stage trial of experimental rheumatoid arthritis drug tabalumab for lack of efficacy. Lilly is still evaluating the drug in the two other late-stage studies.
America's Health Rankings lists Indiana 41st in its annual review, which was released Tuesday. Obesity, sedentary habits, high smoking rates, low public health funding and air pollution contributed to Indiana’s low rank.
Eli Lilly and Co. notified Canada it plans to file a trade complaint, claiming court decisions invalidating one of the company’s patents breach international obligations.
Local firm has carved out niche building for hospitals, physician groups.
Catamaran Corp. will add 50 jobs in Indianapolis over the next year to help it provide pharmacy-benefit-management services to the Indiana Medicaid program. The Illinois-based company will open an office downtown Tuesday to kick off its six-year, $60 million contract with the state.
Even as the rising cost of medical benefits has moderated, 11 percent of Indiana employers with 10 or more workers say they will terminate their medical coverage within the next five years, according to the latest survey from the benefits consulting firm Mercer.
Carmel-based ABC Homecare LLC closed last week after state and federal authorities cut off its access to Medicare and Medicaid reimbursement due to deficiencies cited by the Indiana State Department of Health.
Novia CareClinics LLC, which operates 50 clinics statewide, made its latest clinic open to other employers. Harrison College, Plews Shadley Racher & Braun LLP and McFarling Foods Inc. have joined.
The $2.5 million expansion will add 7,000 square feet of meeting and office space to Fairbanks’ 86-bed hospital for patients trying to recover from drug and alcohol addictions.
The efforts of Indianapolis-based Timmy Global Health to improve health in Latin America, the Caribbean and Africa while exposing hundreds of students to the realities of the medical industry have earned it an appearance on network TV and a shot at a $1 million unrestricted grant.
China takes eight years longer on average to approve drugs than other major countries, and U.S. drugmakers are looking at ways to help speed things up, Eli Lilly and Co. CEO John Lechleiter said.
Merck & Co. and Endocyte Inc. said Tuesday that European Union regulators will review their drug vintafolide as a treatment for ovarian cancer.
A new set of projections released Monday estimates that expanding Medicaid coverage as called for in President Obama’s 2010 health reform law would cost the state government less than $54 million per year on average over the next decade—far lower than projections issued by the actuarial firm hired by Indiana Gov. Mitch Daniels’ administration.
IU Health and Community enjoyed net gains of $267 million and $23 million, respectively, from the hospital assessment fee program during the fiscal year ended June 30.
Now that the election is over, it seems clearer that the Patient Protection and Affordable Care Act, or Obamacare, will likely move forward. The question is whether business owners will be able to steer their employees to state exchanges and wash their hands of health care coverage.
Vasc-Alert proves its technology, plans to expand into Europe.
After decades of slow adoption, health information technology now threatens to completely disrupt health care, in a good way, dramatically improving quality of care. The question is, will federal regulators stand in the way?
Indiana's top lawmakers said Monday they're not sure what to expect from the federal health care law other than greater costs at a time the state's budget is already stretched thin.
Bloomington-based Cook Medical won approval for the first drug-coated stent for clogged leg arteries in the United States, which accounts for 40 percent of the soon-to-be $3 billion market.
Eli Lilly and Co. said Monday it plans to give $12.4 million to the United Way, the largest single charitable donation in the company’s history.
